- Lobbying
- John AND Boyer
Lobbying Arrangements Results for 'John Boyer'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues pertaining to regulations on food manufacturing |
The Jel Sert Company
|
BGR Government Affairs | |||
Details Issues related to drug disposal. |
MAXIMUS, Inc.
|
in-house lobbying | |||
Details Provide strategic advice and counsel on legislative or regulatory actions that could impact the biopharmaceutical industry |
Karyopharm Therapeutics Inc.,
|
BGR Government Affairs | |||
Details Provide strategic guidance and counsel on issues impacting the Company. |
Anheuser-Busch Companies
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biopharmaceutical industry generally, and/ Celgene specifically |
Celgene Corporation
|
BGR Government Affairs | |||
Details Strategic guidance and counsel on regulations and legislations related to NJOY products and business interests. |
NJOY, LLC
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact, pharmaceutical and biotechnology manufacturers. |
Genentech, Inc.
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the gene therapies, drug pricing and other issues that impact the industry generally, and bluebir... |
bluebird bio
|
BGR Government Affairs | |||
Details Provide monitoring, analysis, advise and support services related to legislative and administrative policies impacting the tobacco industry |
RAI Services Company
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biopharmaceutical industry generally, and/ Sobi North America specifically. |
Sobi North America
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to pending healthcare legislation and the potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C pol... |
Gilead Sciences, Inc.
|
BGR Government Affairs | |||
Details Federal legislation pertaining to medical and pharmaceutical product distribution and medical device manufacturing |
Cardinal Health
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally, and/ Merck specifically |
Merck & Co., Inc.
|
BGR Government Affairs | |||
Details Advise client on legislative and administrative policy-making related to the bio-pharmaceutical industry generally, and client priorities specifically. Includes FDA and CMS related matters, as well... |
Avanir Pharmaceuticals, Inc.
|
BGR Government Affairs | |||
Details Provide strategic guidance and counsel on potential changes to FDA regulations |
Flexion Therapeutics, Inc.
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally, and Amarin Pharm Inc. specifically |
Amarin Pharm Inc.
|
BGR Government Affairs | |||
Details Provide strategic guidance and advocacy on potential regulations and/or legislation impacting food innovation |
Impossible Foods Inc.
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biotechnology industry |
Sanofi US Services, Inc.
|
BGR Government Affairs | |||
Details Providing advice, counsel, and services to support the Pharma & Biopharma Outsourcing Association's public policy priorities |
Pharma & Biopharma Outsourcing Association
|
BGR Government Affairs | |||
Details Advise client on legislative and administrative policy-making related to the bio-pharmaceutical industry generally, and client priorities specifically. Includes FDA and CMS related matters, as well... |
Alnylam Pharmaceuticals, Inc.
|
BGR Government Affairs | |||
Details Potential changes to structure and reimbursement for Medicare Part D; H.R.5376 - Inflation Reduction Act of 2022 - issues related to implementation. Regulatory and legislative health care issues im... |
NEUROCRINE BIOSCIENCES, INC
|
in-house lobbying | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation on drug disposal programs. |
DisposeRx, Inc.
|
BGR Government Affairs | |||
Details Medicare coverage for colon cancer screening |
Epigenomics, Inc.
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally, and Baudax Bio, Inc. specifically. |
Baudax Bio, Inc. (formerly known as Recro Pharma, Inc.)
|
BGR Government Affairs | |||
Details Provide guidance and strategic advice regarding FDA regulation of medical devices, including diagnostic tests |
Advanced Medical Technology Association
|
BGR Government Affairs | |||
Details Provide analysis and strategic advocacy support services to Edwards Lifesciences public policy priorities, including FDA regulatory and CMS coverage and reimbursement issue |
Edward Lifesciences LLC
|
BGR Government Affairs | |||
Details Provide strategic counsel and advocate on issues related to the biopharmaceutical industry generally, and Alkermes, Inc. specifically |
Alkermes, Inc.
Biopharmaceutical company |
BGR Government Affairs | |||
Details Provide guidance and advocacy with regard to regulations and legislation that could impact the pharmaceutical industry generally, and Zogenix specifically. |
Zogenix, Inc.
|
BGR Government Affairs | |||
Details Provide policy analysis, strategic advice and direct advocacy support to Walgreens related to public policy priorities for the retail pharmacy industry |
Walgreen Co.
|
BGR Government Affairs | |||
Details Strategic advice and counsel on issues impacting gene and cell therapy development and access |
American Society of Gene and Cell Therapy
|
BGR Government Affairs | |||
Details Provide lobbying support on key issues and providing intelligence and policy tracking for relevant federal policy developments that could impact the pharmaceutical and medical device industry gener... |
Bayer Corporation
|
BGR Government Affairs | |||
Details Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics; implementation of health care reform; PDUFA; FDA reform; Trade issues |
Eli Lilly & Co, Inc.
|
BGR Government Affairs | |||
Details Provide guidance and advocacy with regard to regulations and legislation that could impact the pharmaceutical industry generally, and/ Horizon specifically. |
Horizon Pharma
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally and/or Pfizer specifically. |
PFIZER, INC
|
BGR Government Affairs | |||
Details H.R.1818 & S.1561 Aviation Workforce Development Act H.R.2879 National Center for the Advancement of Aviation Act H.R.3935 Securing Growth and Robust Leadership in American Aviation (SGRLAA) Act H.... |
Aircraft Owners & Pilots Association
|
in-house lobbying | |||
Details Advise and advocate on clients behalf regarding ongoing public policy concerns impacting the innovative biopharmaceutical industry in Congress and throughout the Administration. |
Pharmaceutical Research and Manufacturers of America
|
BGR Government Affairs | |||
Details Strategic guidance and counsel on maintaining and strengthening the employer-based health care system, and advise the client on legislative and regulatory issues. |
Lockton Management, LLC
|
BGR Government Affairs | |||
Details Advise and advocate on client's behalf regarding ongoing public policy concerns impacting the innovative biotechnology industry in Congress and throughout the Administration |
Biotechnology Innovation Organization
|
BGR Government Affairs | |||
Details Strategic guidance and advocacy on health care related issues to include: healthcare reform, HIV/AIDS, bio-defense, Medicare/Medicaid and FDA |
GlaxoSmithKline, INC
|
BGR Government Affairs | |||
Details Provide advice and strategic counsel with regard to matters that could impact biopharmaceutical manufacturers generally and Amgen specifically, including Medicare Part D, Medicare Part B, Health Ca... |
Amgen Inc.
|
BGR Government Affairs | |||
Details Provide guidance and counsel with regard to federal medical device policy and regulatory issues and reimbursement issues within Medicare program, including IPPS Regulation, and FDA regulatory policy. |
Abiomed Inc.
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biopharmaceutical industry generally such as drug pricing and telehealth policy |
Neurocrine Biosciences, Inc.
|
BGR Government Affairs | |||
Details H.R. 4368: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 5893: Commerce, Justice, Science, and Related Agencies Appropriations Act... |
Pharmaceutical Research and Manufacturers of America
|
in-house lobbying | |||
Details Antibiotic Use in Livestock ---H.R.4012: To repeal the guidance titled "CVM GFI #263 Recommendations for Sponsors of Medically Important Antimicrobial Drugs Approved for Use in Animals to Voluntar... |
Biotechnology Innovation Organization
|
in-house lobbying |